openPR Logo
Press release

Decongestant Market worth $10.13 billion by 2030, growing at a CAGR of 6.22% - Exclusive Report by 360iResearch

08-12-2024 01:05 PM CET | Health & Medicine

Press release from: 360iResearch

Decongestant Market | 360iResearch

Decongestant Market | 360iResearch

The "Decongestant Market by Type (Drops, Flavoured Powders, Liquids/Syrups), Category (Nasal Decongestant, Oral Decongestant, Topical Decongestant), Indication, Distribution Channel - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/decongestant

The market research on decongestants encompasses a detailed analysis of products used to alleviate nasal congestion caused by conditions such as colds, allergies, and sinusitis. The scope includes over-the-counter (OTC) drugs, prescription medications, natural or herbal remedies, and devices like nasal sprays and steam inhalers. Decongestants, pharmaceutical drugs that relieve nasal congestion in the upper respiratory tract by narrowing the blood vessels, are essential for individuals with nasal congestion as they improve breathing and overall quality of life. The application spans medical treatments, OTC availability, prescription use for chronic conditions, and increasing adoption of natural remedies. The end-use scope includes distribution channels like pharmacies, retail drug stores, hospitals, clinics, online pharmacies, and home care settings. Several factors drive market growth, including the prevalence of respiratory conditions, rising urbanization and pollution, an aging population, technological advancements, and increased awareness and accessibility. Opportunities include the expansion of e-commerce, growing consumer preference for natural remedies, and untapped potential in emerging markets. Recommendations involve strengthening digital marketing, investing in research and development (R&D) for plant-based decongestants, and forming strategic alliances in developing regions. Challenges such as side effects and health risks, stringent regulatory guidelines, market saturation, and a lack of consumer education affect market growth. Innovation areas for business growth include developing decongestants with minimal side effects, enhancing delivery mechanisms with advanced technologies, and personalized medicine tailored to individual patient needs. The decongestant market features a blend of mature segments and burgeoning niches, with consumer trends moving towards convenience, efficacy, and fewer side effects, pushing for continuous improvement and product diversification.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/decongestant

Market Segmentation & Coverage:

This research report categorizes the Decongestant Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Drops, Flavoured Powders, Liquids/Syrups, Nasal Sprays, and Tablets/Capsules.

Based on Category, market is studied across Nasal Decongestant, Oral Decongestant, and Topical Decongestant.

Based on Indication, market is studied across Allergies, Cold, Hay Fever, Rhinitis, and Sinusitis.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Profiles:

The report delves into recent significant developments in the Decongestant Market, highlighting leading vendors and their innovative profiles. These include Alcon, Aptar Pharma, AstraZeneca PLC, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Cipla Ltd., Dr. Reddy's Laboratories Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Haleon Group of Companies, Johnson & Johnson Services, Inc., Perrigo Company PLC, Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Boots Company PLC, Viatris, Inc., and Walgreen Co..

Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Decongestant Market

We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Decongestant Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Decongestant Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.

Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/decongestant

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Decongestant Market, by Type
7. Decongestant Market, by Category
8. Decongestant Market, by Indication
9. Decongestant Market, by Distribution Channel
10. Americas Decongestant Market
11. Asia-Pacific Decongestant Market
12. Europe, Middle East & Africa Decongestant Market
13. Competitive Landscape
14. Competitive Portfolio

Read More @ https://www.360iresearch.com/library/intelligence/decongestant

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Decongestant Market worth $10.13 billion by 2030, growing at a CAGR of 6.22% - Exclusive Report by 360iResearch here

News-ID: 3619696 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Decongestant

Decongestant Market Future Business Opportunities 2025-2032 | Johnson & Johnson, …
Decongestant Market is estimated to be valued at USD 17.88 Bn in 2025 and is expected to reach USD 27.97 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. The latest Decongestant Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue,
Decongestant Market Future Business Opportunities 2024-2031 | Johnson & Johnson, …
A recent report titled "Decongestant Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Decongestant market has
Decongestant Market Future Business Opportunities 2024-2031 | Johnson & Johnson, …
Decongestant Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Decongestant Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Decongestant market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Decongestant
Decongestant Market Size is Likely to Experience a Huge Growth of by 2030
Global Decongestant Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis Decongestant Market Overview The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Decongestant Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the projected trajectory of
Decongestant Market Size is Likely to Experience a Huge Growth of by 2030
Global Decongestant Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis Decongestant Market Overview The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Decongestant Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the projected trajectory of
Nasal Decongestant Market Research Report, Growth Trends and Competitive Analysi …
Sinusitis can be acute or chronic, with different germs such as bacteria and viruses blocking the nasal cavities or filling them with fluid if not treated. Colds, fevers, headaches, sore throats, coughs, and other symptoms are prevalent. Sinusitis can progress to complications such as a brain abscess and meningitis if it is not treated or identified. Nasal Decongestant industry development was driven by expanded spending in both general and strength medication